THE CREST SYNDROME - A DISTINCT SEROLOGIC ENTITY WITH ANTICENTROMERE ANTIBODIES
THE CREST SYNDROME - A DISTINCT SEROLOGIC ENTITY WITH ANTICENTROMERE ANTIBODIES
复制标题
DOI:
10.1016/0002-9343(80)90462-3
复制
发表时间:
1980-01-01
影响因子:
5.9
通讯作者:
KINSELLA, TD
中科院分区:
文献类型:
--
作者:
FRITZLER, MJ;KINSELLA, TD
The CREST syndrome is a variant of systemic sclerosis, characterized by the presence of calcinosis, Raynaud''s phenomenon, esophageal motility abnormalities, sclerodactyly and telangiectasia. The serums of 27 patients with the CREST syndrome were examined for the presence of antinuclear antibodies. Of 27 serums, 26 (98%) contained high titers (> 1:80) of an antibody that produces a discrete speckled pattern of immunofluorescence on a human laryngeal carcinoma cell line (HEp-2). The antibody reacted with the centromeric region of metaphase chromosomes. This antibody was found in 3 of 14 patients with Raynaud''s disease, in 1 of 60 patients with systemic lupus erythematosus, in 3 of 26 patients with systemic sclerosis with diffuse scleroderma and in 1 of 15 patients with mixed connective tissue disease. The antibody was not detected in the serums of patients with rheumatoid arthritis, Sjogren''s sicca complex or linear scleroderma. Patients with osteoarthritis who were age- and sex-matched to the group with the CREST syndrome did not have anti-centromere antibodies. Autoantibodies found in other connective tissue diseases (anti-DNA, anti-RNP [ribonucleoprotein] and Sjogren''s syndrome antigen B (anti-SS-B)) were not found in serums from patients with the CREST syndrome. A case report illustrating the appearance of the anticentromere antibody at a time when Raynaud''s phenomenon antedated the clinical diagnosis of CREST syndrome is presented.